Furthermore, CCT6A high expression correlates with elevated clinical stage, larger tumor size, nodal statu,s and Scarff–Bloom–Richardson grade in breast cancer patients; and its high expression correlates with larger tumor size as well as severer tumor invasion in colorectal cancer patients [17, 26, 27]. This evidence concerns the gene CCT6A and neoplasm.